DrugPatentWatch Database Preview
Sun Pharm Inds Inc Company Profile
What is the competitive landscape for SUN PHARM INDS INC, and when can generic versions of SUN PHARM INDS INC drugs launch?
SUN PHARM INDS INC has eighty-one approved drugs.
There are five US patents protecting SUN PHARM INDS INC drugs. There is one tentative approval on SUN PHARM INDS INC drugs.
Summary for Sun Pharm Inds Inc
| US Patents: | 5 |
| Tradenames: | 68 |
| Ingredients: | 65 |
| NDAs: | 81 |
Drugs and US Patents for Sun Pharm Inds Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | METHIMAZOLE | methimazole | TABLET;ORAL | 040870-002 | Sep 25, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sun Pharm Inds Inc | PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET;ORAL | 078194-003 | Jun 29, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sun Pharm Inds Inc | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 078231-001 | Nov 30, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Sun Pharm Inds Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | CREAM;TOPICAL | 019967-001 | Dec 27, 1990 | 4,619,921 | ➤ Try a Free Trial |
| Sun Pharm Inds Inc | ULTRAVATE | halobetasol propionate | OINTMENT;TOPICAL | 019968-001 | Dec 17, 1990 | 4,619,921 | ➤ Try a Free Trial |
| Sun Pharm Inds Inc | LAC-HYDRIN | ammonium lactate | LOTION;TOPICAL | 019155-001 | Apr 24, 1985 | 4,105,783 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for SUN PHARM INDS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 25 mg | ➤ Subscribe | 2016-05-16 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-01-07 |
| ➤ Subscribe | Capsules | 35 mg | ➤ Subscribe | 2015-11-25 |
| ➤ Subscribe | Capsules | 30 mg and 40 mg | ➤ Subscribe | 2012-12-31 |
| ➤ Subscribe | Capsules | 20 mg | ➤ Subscribe | 2013-06-19 |
International Patents for Sun Pharm Inds Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Portugal | 1318791 | ➤ Try a Free Trial |
| European Patent Office | 2964195 | ➤ Try a Free Trial |
| Spain | 2225600 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Sun Pharm Inds Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 330 | Luxembourg | ➤ Try a Free Trial | CERTIFICATE TITLE: UNE COMBINAISON D'OLMESARTAN MEDOXOMIL, OPTIONNELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE ET D'HYDROCHLOROTHIAZIDE (OLMETEC PLUS) |
| C/GB02/037 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: TELMISARTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/02/213/001 20020419; UK EU/1/02/213/002 20020419; UK EU/1/02/213/003 20020419; UK EU/1/02/214/004 20020419; UK EU/1/02/213/005 20020419; UK EU/1/02/213/006 20020419; UK EU/1/02/213/007 20020419; UK EU/1/02/213/008 20020419; UK EU/1/02/213/009 20020419; UK EU/1/02/213/010 20020419 |
| 0714 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: ZOLPIDEM EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NATIONAL REGISTRATION NO/DATE: RVG 108438 - 439 20160624; REGISTRATION NO/DATE: BE424286 20120718 BE424295 20120718 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
